Evolus (EOLS) FCF Margin Growth (1y) (2020 - 2026)
Evolus (EOLS) FCF Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 74.00 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -1,043.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -573.00 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 734.00 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 301.00 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -45,890.00 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 610.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 407.00 |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | 910.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 910.00 |
| Dec 31, 2025 | 549.00 |
| Sep 30, 2025 | -1,277.00 |
| Jun 30, 2025 | -2,636.00 |
| Mar 31, 2025 | -496.00 |
| Dec 31, 2024 | 609.00 |
| Sep 30, 2024 | -849.00 |
| Jun 30, 2024 | 1,715.00 |
| Mar 31, 2024 | 3,157.00 |
| Dec 31, 2023 | 2,240.00 |
| Sep 30, 2023 | 5,041.00 |
| Jun 30, 2023 | 2,932.00 |
| Mar 31, 2023 | 6,280.00 |
| Dec 31, 2022 | 415.00 |
| Sep 30, 2022 | 7,076.00 |
| Jun 30, 2022 | -11,857.00 |
| Mar 31, 2022 | -4,454.00 |
| Dec 31, 2021 | -1,098.00 |
| Sep 30, 2021 | -5,274.00 |
| Jun 30, 2021 | 25,189.00 |